Skip to main content
Clinical Trials/JPRN-jRCTs052230043
JPRN-jRCTs052230043
Recruiting
N/A

A study of the short-term gait improvement effect using a biological signal reaction type motor function improvement device for gait instability in patients with Parkinson's disease. a randomized controlled trial

Kohara Nobuo0 sites30 target enrollmentJune 20, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson's disease
Sponsor
Kohara Nobuo
Enrollment
30
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 20, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kohara Nobuo

Eligibility Criteria

Inclusion Criteria

  • 1\)Those who have been diagnosed with clinically established or clinically probable cases according
  • to the clinical diagnostic criteria for Parkinson's disease by the Movement Disorder Society (MDS).
  • 2\)Hoehn\-Yahr Scale stage III
  • 3\)Those who have not changed the type and dos e of Parkinson's drug before 4 weeks of the date o f consent acquisition and have no plans to change it while participating in clinical research.
  • 4\)Those who do not have a clear wearing\-off phe nomenon.
  • 5\)Those who are judged by the doctor that their g eneral condition is stable and that standing / walki ng training can be carried out.
  • 6\)Those who can stand up and sit and walk 10 m or more without assistance (regardless of the use of assistive devices).
  • 7\)Those who are 20 years old or older at the time of consent
  • 8\)Those who have obtained the document conse nt of the subject.
  • 9\)Those who meet the following conditions descri bed in the HAL package insert

Exclusion Criteria

  • 1\)Those who the doctor judges to be inappropriat e, such as improper standing and walking training 2\)Those who have difficulty wearing HAL due to p hysical deformation, etc.
  • 3\)Those who have difficulty in attaching electrode s due to skin diseases, etc.
  • 4\)Those who are pregnant
  • 5\)Those who have a cognitive function test (MMS
  • E) of 23 points or less.
  • 6\)In addition, those who are judged to be inappro priate for conducting this research by the principal investigator or the other investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials